Position in EOLS
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$193,133
New position
Shares Held
27,829
first reported quarter
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 23 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Concurrent Investment Advisors, LLC holds $11,325,302 across 18 Drug Manufacturers - Specialty & Generic names. EOLS ranks #12 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
34,405 | $2,472,342 | |
| 2 | GLAS |
Glass House Brands Inc.
|
147,253 | $1,914,289 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
35,272 | $1,222,879 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
60,025 | $1,039,032 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
1,852 | $1,003,468 | |
| 6 | TRLV |
Trulieve Cannabis Corp.
|
100,761 | $990,480 | |
| 7 | VTRS |
Viatris Inc
|
45,255 | $718,648 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
11,370 | $385,214 |
All Filings in EOLS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $193,133 | 27,829 | Shares | Sole | 2026-07-27 | |
| No filing history on record for this holder in this stock. | ||||||